Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: A comparison with the general population

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 10, 2014, Pages 704-711

  Leth, Steffen ^a   Jensen Fangel, Soren ^a   Ostergaard, Lars ^a   Rostved, Andreas Arendtsen ^b   Jespersen, Bente ^a   Sogaard, Ole Schmeltz ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

End stage renal disease; Pneumocystis pneumonia; Renal transplant recipients; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROSCLEROSIS; PERITONEAL DIALYSIS; PNEUMOCYSTIS PNEUMONIA; POPULATION DYNAMICS; REGISTER; RISK FACTOR; ADOLESCENT; ADVERSE EFFECTS; COMPLICATION; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MICROBIOLOGY; MIDDLE AGED; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DENMARK; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84907159759     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2014.936492     Document Type: Article

References (40)

1. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus:a new immunosuppressive agent. Am J Heal Syst Pharm 1995; 52:1521-35.
2. Weir MR, Mulgaonkar S, Chan L, Shidban H, Waid TH, Preston D, et al. Mycophenolate mofetil-based immunosup-pression with sirolimus in renal transplantation:a randomized, controlled Spare-the-Nephron trial. Kidney Int 2011; 79:897-907.
3. Van Leeuwen MT, Webster AC, McCredie MRE, Stewart JH, McDonald SP, Amin J, et al. Effect of reduced immunosup-pression after kidney transplant failure on risk of cancer:population based retrospective cohort study. BMJ 2010; 340:c570.
4. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC. Analysis of USRDS:incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009; 88:135-41.
5. Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications after kidney transplantation:current epidemiology and associated risk factors. Clin Transplant 2006; 20:401-9.
6. Grimaldi A, Barletta A, Rascente M, Pisani F, Iaria G, Mac-carone D, et al. Infectious complications in the renal transplant recipient. Transplant Proc 2005; 37:2502-3.
7. Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand MR. Infectious complications after kidney transplantation:a single-center experience. Transpl Infect Dis 2007; 9:302-9.
8. Gunst JD, Jensen-Fangel S, Jespersen B, Ostergaard L, Søgaard OS. Central nervous system infections among individuals with and without end-stage renal disease. J Infect 2013; 67:19-26.
9. Nielsen LH, Jensen-Fangel S, Jespersen B, Ostergaard L, Søgaard OS. Risk and prognosis of hospitalization for pneumonia among individuals with and without functioning renal transplants in Denmark:a population-based study. Clin Infect Dis 2012; 55:679-86.
10. Afessa B. Pulmonary complications of HIV Infection. Chest J 1998; 113:1225.
11. Meuwissen JH, Tauber I, Leeuwenberg AD, Beckers PJ, Sie-ben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 1977; 136:43-9.
12. Ponce CA, Gallo M, Bustamante R, Vargas SL. Pneumo-cystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 2010; 50:347-53.
13. Vargas SL, Hughes WT, Santolaya ME, Ulloa A V, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumo-cystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001; 32:855-61.
14. Hirschl MM, Derfler K, Janata O, Heinz G, Sertl K, Balcke P. Accumulation of Pneumocystis carinii pneumonia in patients after kidney transplantation. Clin Nephrol 1992; 37:105.
15. Schmoldt S, Schuhegger R, Wendler T, Huber I, Sollner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol 2008; 46:966-71.
16. De Boer MGJ, Bruijnesteijn van Coppenraet LES, Gaasbeek A, Berger SP, Gelinck LBS, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients:inter-human transmission or a common environmental source? Clin Infect Dis 2007;44:1143-9.
17. De Boer MGJ, de Fijter JW, Kroon FP. Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients:a systematic review. Med Mycol 2011; 49:673-80.
18. Fishman JA; AST Infectious Diseases Community of Practice. Introduction:infection in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4):S3-6.
19. Rostved AA, Sassi M, Kurtzhals JA, Sørensen SS, Rasmussen A, Ross C, et al. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 2013; 96:834-42.
20. Shelhamer JH, Gill VJ, Quinn TC, Crawford SW, Kovacs JA, Masur H, et al. The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 1996; 124:585-99.
21. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneu-mocystis pneumonia in non-HIV immunocompromised patients with pulmonary infi ltrates. Chest 2009; 135:655-61.
22. Hui M, Kwok WT. Pneumocystis carinii pneumonia in Hong Kong:a 10 year retrospective study. J Med Microbiol 2006; 55:85-8.
23. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11:954-63.
24. El-Faramawi M, Rohr N, Jespersen B. Steroid-free immuno-suppression after renal transplantation-long-term experience from a single centre. Nephrol Dial Transplant 2006; 21:1966-73.
25. Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumo-cystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28:240-6.
26. Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodefi ciency virus-negative immunocompromised patients. Clin Microbiol Rev 2004; 17:770-82, table of contents.
27. Gerrard JG. Pneumocystis carinii pneumonia in HIV-nega-tive immunocompromised adults. Med J Aust 1995; 162:233-5.
28. Radisic M, Lattes R, Chapman JF, del Carmen Rial M, Guardia O, Seu F, et al. Risk factors for Pneumocystis cari-nii pneumonia in kidney transplant recipients:a case-control study. Transpl Infect Dis 2003; 5:84-93.
29. Benedetti E, Sileri P, Pursell KJ, Giacomoni A, Tzoracolefthe-rakis E, Rastellini C, et al. Treatment of severe pneumonia in kidney transplant recipients. Transplant Proc 2001; 33:3652.
30. De Boer MGJ, Kroon FP, le Cessie S, de Fijter JW, van Dis-sel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis 2011; 13:559-69.
31. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients:a summary. Kidney Int 2010; 77:299-311.
32. European best practice guidelines for renal transplantation. Section IV:Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant 2002; 17(Suppl 4):36-9.
33. Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 2013; 13(Suppl 4):272-9.
34. Dominguez J, Mahalati K, Kiberd B, McAlister VC, MacDonald AS. Conversion to rapamycin immunosuppres-sion in renal transplant recipients:report of an initial experience. Transplantation 2000; 70:1244-7.
35. Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant 2011; 26:2013-7.
36. Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Ney-lan J. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts:a phase II trial. Rapa-mune Study Group. Transplantation 1999; 68:1526-32.
37. Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 1996; 62:421-3.
38. Arichi N, Kishikawa H, Mitsui Y, Kato T, Nishimura K, Tachikawa R, et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc 2009; 41:170-2.
39. Bensousan T, Garo B, Islam S, Bourbigot B, Cledes J, Garre M. Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet 1990; 336:1066-7.
40. Gianella S, Haeberli L, Joos B, Ledergerber B, Wuthrich RP, Weber R, et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 2010; 12:1-10.